Auditor15 May 2026, 07:01 pm
Aarti Drugs Re-appoints Cost & Internal Auditors, FY26 Results Approved
AI Summary
Aarti Drugs Ltd's board re-appointed M/s GMVP & Associates LLP as Cost Auditor for FY27 and M/s Raman S. Shah & Co. as Internal Auditor for three years starting April 1, 2026. The board also approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Additionally, the Risk Management Committee was reconstituted with the inclusion of Shri Narendra J. Salvi.
Key Highlights
- M/s GMVP & Associates LLP re-appointed as Cost Auditor for FY 2026-27.
- M/s Raman S. Shah & Co. re-appointed as Internal Auditor for three years starting April 1, 2026.
- Audited standalone and consolidated financial results for FY26 approved.
- Risk Management Committee reconstituted with Shri Narendra J. Salvi as a member.
Price Impact
More from AARTIDRUGS